Cephalon Limited

1 Albany Place, Hyde Way, Welwyn Garden City, Hertfordshire, AL7 3BT, UK
Telephone: +44 (0)1707 385800
Fax: +44 (0)1707 385801
WWW: http://www.cephalon.co.uk
Medical Information Direct Line: 0800 783 4869
Medical Information e-mail: ukmedinfo@cephalon.com
Patient Information Leaflet last updated on the eMC: 23/10/2009
PIL Zanaflex

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/10/2009 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 19/07/2009 and displayed until 23/10/2009
Reasons for adding or updating:
  • Introduction of new pack/pack size
Updated on 27/08/2008 and displayed until 19/07/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 15/07/2008 and displayed until 27/08/2008
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 24/04/2008 and displayed until 15/07/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 13/03/2008 and displayed until 24/04/2008
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Change of contra-indications
Updated on 01/08/2006 and displayed until 13/03/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 01/08/2001 and displayed until 01/08/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 07/08/2000 and displayed until 01/08/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   tizanidine hydrochloride


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk